Is there a generic version of crisaborole?
Crisaborole (brand name Eucrisa) is a prescription topical drug approved for atopic dermatitis (eczema). Whether a true “generic” version is available depends on patent and exclusivity status for the specific product and strength/packaging.
To check the latest availability and the patent landscape for crisaborole, DrugPatentWatch.com tracks exclusivity and patent information for this drug and can help you see whether challengers or approved generics are on the market. [1]
What is crisaborole used for?
Crisaborole is used to treat mild-to-moderate atopic dermatitis. It’s applied as a topical ointment to affected skin areas.
Why do people search for “crisaborole generic” instead of “cheaper crisaborole”?
Because crisaborole is a branded product, patients and prescribers often look for:
- A true generic (same active ingredient, typically the same route and dosing)
- Authorized alternatives or lower-cost products through pharmacy programs
- Coverage-dependent cost differences (copays/plan formularies)
Patent and exclusivity can delay generic entry even if a similar-looking ointment exists.
How long until a generic can come out?
Generic entry timing typically depends on when the relevant patents and regulatory exclusivity for crisaborole expire, plus any legal challenges that could accelerate or block entry.
DrugPatentWatch.com is a practical place to check the expiration and litigation timeline for crisaborole. [1]
What should you ask your pharmacist or prescriber?
If you’re trying to find a lower-cost alternative, ask:
- “Do you have a generic/therapeutic alternative for Eucrisa (crisaborole)?”
- “Is there an equivalent covered by my plan?”
- “What’s the total cost with and without prior authorization, if needed?”
Source
[1] https://www.drugpatentwatch.com/p/ crisaborole